1. Arginase inhibitor CB-1158 elicits immune-mediated anti-tumor responses as a single agent and enhances the efficacy of other immunotherapies. (December 2016) Authors: Steggerda, S.; Bennett, M.; Chen, J.; Emberley, E.; Gross, M.; Huang, T.; Li, W.; MacKinnon, A.; Makkouk, A.; Marguier, G.; Neou, S.; Pan, A.; Wang, T.; Works, M.; Zhang, J.; Zhang, W.; Parlati, F. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗